Search results
With Duchenne decision ahead, FDA’s Marks pushes for speedy gene therapy approvals
BioPharma Dive via Yahoo Finance· 8 hours agoBut the head of the FDA’s CBER office didn’t tip where the agency stands on potentially broadening...
12-Year-Old Begins Newly Approved Sickle Cell Gene Therapy That Could Provide Cure
Black Enterprise· 8 hours agoKendric Cromer, 12, is the first patient in the United States to undergo a newly approved gene ...
Evotec ends gene therapy business, shuts down facility in Austria
Endpoints News· 2 days agoEvotec has provided further updates to its “priority reset” as the CRDMO exits the gene therapy...
Local cell and gene therapy sector reeled in $7.6B in private investment capital in last five years...
The Business Journals· 18 hours agoThe Philadelphia region is now home to more than 10% of the world’s cell and gene therapy companies....
Bears are Losing Control Over Notable Labs (NTBL), Here's Why It's a 'Buy' Now
Zacks via Yahoo Finance· 6 hours agoNotable Labs (NTBL) witnesses a hammer chart pattern, indicating support found by the stock after...
...California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP)...
WTNH-TV New Haven· 1 day agoAndelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $7.00 Consensus PT from Analysts
ETF DAILY NEWS· 5 days agoTaysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received an average rating of “Buy” from the nine research firms that are currently covering the company, Marketbeat reports.
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive via Yahoo Finance· 1 day agoDive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical part of viral vector-based gene therapy
Flexibility of alternative trial designs crucial for cell and gene therapy research
Clinical Trials Arena via Yahoo Finance· 4 days agoInnovative trial designs, like single group assignment, adaptive, basket, umbrella and platform...
South Africa’s Afrigen targets local diseases with mRNA vaccines
Semafor via Yahoo News· 1 day agoSouth African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist's team...